Distrofia muscular
facioescapulohumeral en Chile:
presentación de serie en hospital de
referencia terciario
Author
dc.contributor.author
Cea Muñoz, Gabriel
Author
dc.contributor.author
Jiménez Espinoza, Daniel
Admission date
dc.date.accessioned
2015-08-19T17:13:48Z
Available date
dc.date.available
2015-08-19T17:13:48Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Rev Med Chile 2015; 143: 304-309
en_US
Identifier
dc.identifier.issn
0034-9887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/132930
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Background: Facioscapulohumeral muscular dystrophy is the third most
common muscular dystrophy with an estimated prevalence of 1 per 20.000 and
a normal life expectancy in the majority of patients. However, approximately
15% of patients become wheelchair bound in the course of their life. It is a hereditary
autosomal dominant disease with high (95%) penetrance by the age of
20, but with variable degree of phenotypic expression even in the same family
group. Symptoms frequently start in the second decade of life, with facial and
scapular weakness. Aim: To report the clinical features of seven patients with
the disease, seen at a public hospital. Material and Methods: Analysis of seven
patients with genetic study seen in a public Hospital in Santiago. Results:
The age of patients fluctuated from 18 to 61 years and four were females. The
mean age at onset of symptoms was 29 years and four had a family history of
the disease. The usual presenting complaint was arm or shoulder asymmetric
weakness. Four patients had bone pain. Facial involvement was present in four.
A genetic study was done in five patients, the other two patients were relatives,
confirming the contraction or lower number of repetitions in D4Z4 region. After
12 years of follow up only 2 patients older than 60 years cannot work and one
female patients is in a semi dependent state at the age of 30. Conclusions: The
clinical workup in the diagnosis and the timely indication of genetic studies are
highlighted, to avoid unnecessary and invasive procedures. The variability in
the phenotypic expression in a similar genetic defect is discussed and the genetic
or epigenetic mechanisms of this muscular dystrophy are described.